Report reveals country has failed to fully regulate trade despite promises to crack down The Chinese government continues to allow the use of pangolin scales for traditional medicine despite promises to crack down on a trade that has made them the most illegally trafficked mammals… Read More »China still allowing use of pangolin scales in traditional medicine
Doctors say patients are seeking to participate in drug’s trials as Regeneron’s stock soar after president touts treatment Doctors are reporting a spike in enquiries by patients for an experimental Covid-19 drug cocktail after Donald Trump called the Regeneron Pharmaceuticals drug “a blessing from God”… Read More »Demand surges for Regeneron drug that Trump claims ‘cures’ Covid-19
Link to drug company boss raises questions about ‘cure’ claims and exclusive access Coronavirus – latest updates See all our coronavirus coverage New questions have emerged over the circumstances in which Donald Trump was given an experimental antibody drug cocktail produced by a golfing acquaintance… Read More »Provider of Trump Covid drug is president’s golf friend
Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team has been to put the president on dexamethasone, a steroid that is proven, thanks to the UK’s Recovery trial, to… Read More »Trump’s steroid Covid treatment adds to confusion over health
Neither remdesivir nor REGN-COV2 have completed large-scale randomised trials, say UK scientists Coronavirus – latest updates See all our coronavirus coverage Scientists still lack conclusive proof that the two anti-Covid drugs given to Donald Trump are clinically effective. UK researchers point out that both medicines… Read More »Anti-Covid treatments being given to Trump are still unproven, say experts
Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is… Read More »UK doing more than most to help poor get Covid vaccine, study finds
Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines… Read More »Show more empathy to boost confidence in vaccines, scientists told
Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot,… Read More »Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief
Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure? The AstraZeneca vaccine trial has been paused – should we be worried? Coronavirus – latest updates See all our coronavirus coverage One of the volunteers in… Read More »Oxford Covid vaccine trial suspension: what happens next?
Authorities order 50% more doses than in 2019 in bid to avoid hospitals being overwhelmed Coronavirus – latest updates See all our coronavirus coverage Italian vaccine manufacturers are scrambling to produce millions of flu vaccination doses amid concern there will not be enough to meet… Read More »Italian vaccine makers in race to produce flu doses before winter
UK drugmaker and Oxford Biomedica to produce more of potential coronavirus product Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has expanded an agreement with Oxford Biomedica to scale up production of its potential Covid-19 vaccine, as the race continues to find an… Read More »AstraZeneca expands Covid-19 vaccine deal as final trials begin
While a cure-all drug or therapy is a long way off, there have been some breakthroughs Many different drugs and therapies are being trialled and used on patients with Covid-19. There are some positive results, which may be beginning to bring the hospital death toll… Read More »Six of the most promising treatments for Covid-19 so far
AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the Oxford University coronavirus vaccine has denied it is in talks with the Trump administration about fast-tracking its vaccine for emergency… Read More »Oxford University Covid-19 vaccine firm denies Trump talks
Russia is not the only country pursuing domestic politics over global cooperation in the fight against coronavirus We’re all waiting for a coronavirus vaccine, but when Russia announced earlier this week that it would be the first country to approve one, nobody rejoiced. Scientists pointed… Read More »‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi
Businesses already struggling with the fallout from Covid-19 will be forced to deal with a mountain of new bureaucracy in the middle of a deep recession The government did not quite achieve the Brexit breakthrough it was seeking on Friday, when there was hope that… Read More »The Guardian view on Brexit bureaucracy: tied up in red tape | Editorial
The trade committee urged ministers to develop “parallel supply chains” as a solution Coronavirus – latest updates See all our coronavirus coverage Britain needs to ensure its stockpile of medicines is replenished to deal with a second wave of coronavirus and any shocks to a… Read More »UK must ensure medicines replenished for Covid-19 second wave
Pharmaceuticals company buys global rights to new technology from Japan’s Daiichi Sankyo Drugmaker AstraZeneca could pay up to $6bn (£4.7bn) for the global rights to a new Japanese cancer treatment. The Anglo-Swedish pharmaceutical company said it would pay $1bn (£800m) up front to its partner… Read More »AstraZeneca signs deal worth up to £4.7bn for cancer treatment
Synairgen’s share price rises 540% on morning of news of successful drugs trial Coronavirus – latest updates See all our coronavirus coverage Three professors at the University of Southampton school of medicine have this week made a “major breakthrough” in the treatment of coronavirus patients… Read More »‘Major’ breakthrough in Covid-19 drug makes UK professors millionaires
AstraZeneca and others should not own a lucrative patent on a medicine that is needed by poor as well as rich nations • See all our coronavirus coverage • Helen Clark is a former prime minister of New Zealand and Winnie Byanyima is UN undersecretary… Read More »The world needs a ‘people’s vaccine’ for coronavirus, not a big-pharma monopoly | Helen Clark and Winnie Byanyima
Stake of 10% in CureVac is part of deal that could eventually be worth more than £800m Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company GlaxoSmithKline has bought a 10% stake in a German biotech company that is a key… Read More »GSK buys £130m stake in German coronavirus vaccine maker
The family behind the firm that made OxyContin denies wrongdoing – but numerous cases against them have been halted while a court deliberates With most Americans transfixed for months by the election, Donald Trump’s impeachment, the coronavirus and economic catastrophes and anti-racism protests, the nation’s… Read More »Activists see Purdue bankruptcy case as last chance to call Sacklers to account
Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients… Read More »
No other country will be able to buy remdesivir, which can help recovery from Covid-19, for next three months at least Coronavirus – latest US updates Coronavirus – latest updates See all our coronavirus coverage The US has bought up virtually all the stocks for… Read More »US secures world stock of key Covid-19 drug remdesivir
Rich countries’ governments are putting all their trust in a marriage of markets and philanthropy called Gavi Vaccines for Covid-19 are coming. Billions of dollars are flowing in, over 100 efforts are under way, and at least 13 leading candidates are already being tested on… Read More »
Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level Twenty years ago this week, an international group of scientists announced it had put together the first genetic blueprint of a… Read More »‘The wondrous map’: how unlocking human DNA changed the course of science
Manufacturers warn they will struggle to meet demand as governments seek to ease pressure on health services Coronavirus – latest updates See all our coronavirus coverage Fears of a second wave of coronavirus have sparked a global scramble for influenza shots from countries that hope… Read More »Demand for flu vaccine soars as countries plan for second Covid-19 wave
